Skin Cancer Diagnostics and Therapeutics Market Report

Global and Region Skin Cancer Diagnostics and Therapeutics Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 30, 2022
  • PAGES：140
  • REPORT CODE：GMM902251
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Squamous-cell carcinoma, and melanoma. Factors such as increasing incidences of skin cancer, favorable government initiatives, the development of novel immunotherapies, and the extension of current therapies are fueling the growth of the market. However, high cost associated with therapy, a stringent regulatory environment, and the lack of awareness in the general population could adversely affect market growth. North America was the largest regional market, in terms of revenue. The high prevalence of skin cancer and its risk factors, a favorable reimbursement environment, and high adoption rate of novel technologies are primary factors behind the large market size. The Asia-Pacific region is expected to grow at a rapid pace over the forecast period, owing to increasing healthcare expenditure and government initiatives aimed at increasing awareness in the developing economies of the region.

    The report details the trend, potential and market size of Skin Cancer Diagnostics and Therapeutics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Skin Cancer Diagnostics and Therapeuticsmarket, defines the market attractiveness level of Skin Cancer Diagnostics and Therapeutics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Skin Cancer Diagnostics and Therapeutics industry, describes the types of Skin Cancer Diagnostics and Therapeutics market, the applications of major players and the market size, and deeply analyzes the current situation of the global Skin Cancer Diagnostics and Therapeutics market and the development prospects and opportunities of Skin Cancer Diagnostics and Therapeutics industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Skin Cancer Diagnostics and Therapeutics market in Chapter 13.

    By Player:

    • Merck & Co, Inc

    • Bristol-Myers Squibb Company

    • Amgen, Inc

    • F Hoffmann-La Roche Ltd

    • Sun Pharmaceutical Industries Ltd

    By Type:

    • Melanoma

    • Non-melanoma

    By End-User:

    • Hospital

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Skin Cancer Diagnostics and Therapeutics Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Skin Cancer Diagnostics and Therapeutics Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Skin Cancer Diagnostics and Therapeutics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Skin Cancer Diagnostics and Therapeutics Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Skin Cancer Diagnostics and Therapeutics Market Analysis and Outlook to 2022

    • 7.1 Global Skin Cancer Diagnostics and Therapeutics Consumption (2017-2022)

    • 7.2 United States Skin Cancer Diagnostics and Therapeutics Consumption (2017-2022)

    • 7.3 Europe Skin Cancer Diagnostics and Therapeutics Consumption (2017-2022)

    • 7.4 China Skin Cancer Diagnostics and Therapeutics Consumption (2017-2022)

    • 7.5 Japan Skin Cancer Diagnostics and Therapeutics Consumption (2017-2022)

    • 7.6 India Skin Cancer Diagnostics and Therapeutics Consumption (2017-2022)

    • 7.7 South Korea Skin Cancer Diagnostics and Therapeutics Consumption (2017-2022)

    8 Region and Country-wise Skin Cancer Diagnostics and Therapeutics Market Analysis and Outlook to 2028

    • 8.1 Global Skin Cancer Diagnostics and Therapeutics Consumption Forecast (2022-2028)

    • 8.2 United States Skin Cancer Diagnostics and Therapeutics Consumption Forecast (2022-2028)

    • 8.3 Europe Skin Cancer Diagnostics and Therapeutics Consumption Forecast (2022-2028)

    • 8.4 China Skin Cancer Diagnostics and Therapeutics Consumption Forecast (2022-2028)

    • 8.5 Japan Skin Cancer Diagnostics and Therapeutics Consumption Forecast (2022-2028)

    • 8.6 India Skin Cancer Diagnostics and Therapeutics Consumption Forecast (2022-2028)

    • 8.7 South Korea Skin Cancer Diagnostics and Therapeutics Consumption Forecast (2022-2028)

    9 Global Skin Cancer Diagnostics and Therapeutics Market Outlook by Types and Applications to 2022

    • 9.1 Global Skin Cancer Diagnostics and Therapeutics Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Melanoma Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Non-melanoma Consumption and Growth Rate (2017-2022)

    • 9.2 Global Skin Cancer Diagnostics and Therapeutics Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Skin Cancer Diagnostics and Therapeutics Market Outlook by Types and Applications to 2028

    • 10.1 Global Skin Cancer Diagnostics and Therapeutics Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Melanoma Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Non-melanoma Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Skin Cancer Diagnostics and Therapeutics Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Skin Cancer Diagnostics and Therapeutics Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Skin Cancer Diagnostics and Therapeutics Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Skin Cancer Diagnostics and Therapeutics Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Skin Cancer Diagnostics and Therapeutics Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Skin Cancer Diagnostics and Therapeutics Market Competitive Analysis

    • 14.1 Merck & Co, Inc

      • 14.1.1 Merck & Co, Inc Company Details

      • 14.1.2 Merck & Co, Inc Skin Cancer Diagnostics and Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Merck & Co, Inc Skin Cancer Diagnostics and Therapeutics Product and Service

    • 14.2 Bristol-Myers Squibb Company

      • 14.2.1 Bristol-Myers Squibb Company Company Details

      • 14.2.2 Bristol-Myers Squibb Company Skin Cancer Diagnostics and Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Bristol-Myers Squibb Company Skin Cancer Diagnostics and Therapeutics Product and Service

    • 14.3 Amgen, Inc

      • 14.3.1 Amgen, Inc Company Details

      • 14.3.2 Amgen, Inc Skin Cancer Diagnostics and Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Amgen, Inc Skin Cancer Diagnostics and Therapeutics Product and Service

    • 14.4 F Hoffmann-La Roche Ltd

      • 14.4.1 F Hoffmann-La Roche Ltd Company Details

      • 14.4.2 F Hoffmann-La Roche Ltd Skin Cancer Diagnostics and Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 F Hoffmann-La Roche Ltd Skin Cancer Diagnostics and Therapeutics Product and Service

    • 14.5 Sun Pharmaceutical Industries Ltd

      • 14.5.1 Sun Pharmaceutical Industries Ltd Company Details

      • 14.5.2 Sun Pharmaceutical Industries Ltd Skin Cancer Diagnostics and Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Sun Pharmaceutical Industries Ltd Skin Cancer Diagnostics and Therapeutics Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Skin Cancer Diagnostics and Therapeutics

    • Figure Skin Cancer Diagnostics and Therapeutics Picture

    • Table Global Skin Cancer Diagnostics and Therapeutics Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Skin Cancer Diagnostics and Therapeutics Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Skin Cancer Diagnostics and Therapeutics Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Skin Cancer Diagnostics and Therapeutics Consumption by Country (2017-2022)

    • Figure United States Skin Cancer Diagnostics and Therapeutics Consumption and Growth Rate (2017-2022)

    • Table Europe Skin Cancer Diagnostics and Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure China Skin Cancer Diagnostics and Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Japan Skin Cancer Diagnostics and Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure India Skin Cancer Diagnostics and Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure South Korea Skin Cancer Diagnostics and Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Global Skin Cancer Diagnostics and Therapeutics Consumption Forecast by Country (2022-2028)

    • Figure United States Skin Cancer Diagnostics and Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Skin Cancer Diagnostics and Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Skin Cancer Diagnostics and Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Skin Cancer Diagnostics and Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Skin Cancer Diagnostics and Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Skin Cancer Diagnostics and Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Melanoma Consumption and Growth Rate (2017-2022)

    • Figure Global Non-melanoma Consumption and Growth Rate (2017-2022)

    • Figure Global Hospital Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Melanoma Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Non-melanoma Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Skin Cancer Diagnostics and Therapeutics Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Skin Cancer Diagnostics and Therapeutics Export by Region (Top 5 Countries) (2017-2028)

    • Table Merck & Co, Inc (Foundation Year, Company Profile and etc.)

    • Table Merck & Co, Inc Skin Cancer Diagnostics and Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck & Co, Inc Skin Cancer Diagnostics and Therapeutics Product and Service

    • Table Bristol-Myers Squibb Company (Foundation Year, Company Profile and etc.)

    • Table Bristol-Myers Squibb Company Skin Cancer Diagnostics and Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bristol-Myers Squibb Company Skin Cancer Diagnostics and Therapeutics Product and Service

    • Table Amgen, Inc (Foundation Year, Company Profile and etc.)

    • Table Amgen, Inc Skin Cancer Diagnostics and Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Amgen, Inc Skin Cancer Diagnostics and Therapeutics Product and Service

    • Table F Hoffmann-La Roche Ltd (Foundation Year, Company Profile and etc.)

    • Table F Hoffmann-La Roche Ltd Skin Cancer Diagnostics and Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table F Hoffmann-La Roche Ltd Skin Cancer Diagnostics and Therapeutics Product and Service

    • Table Sun Pharmaceutical Industries Ltd (Foundation Year, Company Profile and etc.)

    • Table Sun Pharmaceutical Industries Ltd Skin Cancer Diagnostics and Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sun Pharmaceutical Industries Ltd Skin Cancer Diagnostics and Therapeutics Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US